Baker Bros. Advisors’s Adaptimmune Therapeutics ADAP Stock Holding History

Quarter	Market Value	Status	Shares	Shares Change %	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-2,343,695	Closed	-$2.28M	–	94
2024 Q2	$2.28M	Sell	2,343,695 -8,443,327	-78%	-$8.23M	0.03%	78
2024 Q1	$17M	Sell	10,787,022 -182,260	-2%	-$288K	0.21%	41
2023 Q4	$8.7M	Hold	10,969,282	–	–	0.1%	51
2023 Q3	$8.56M	Hold	10,969,282	–	–	0.05%	48
2023 Q2	$10.1M	Buy	10,969,282 +1,138,405	+12%	+$1.05M	0.06%	55
2023 Q1	$10.7M	Hold	9,830,877	–	–	0.06%	52
2022 Q4	$14.4M	Hold	9,830,877	–	–	0.09%	50
2022 Q3	$10.6M	Hold	9,830,877	–	–	0.07%	62
2022 Q2	$16.7M	Hold	9,830,877	–	–	0.09%	55
2022 Q1	$20.3M	Hold	9,830,877	–	–	0.12%	52
2021 Q4	$36.9M	Hold	9,830,877	–	–	0.18%	43
2021 Q3	$50.8M	Hold	9,830,877	–	–	0.22%	35
2021 Q2	$41.9M	Hold	9,830,877	–	–	0.18%	42
2021 Q1	$52.2M	Hold	9,830,877	–	–	0.23%	38
2020 Q4	$53M	Buy	9,830,877 +3,500,523	+55%	+$18.9M	0.2%	33
2020 Q3	$50.5M	Sell	6,330,354 -344,827	-5%	-$2.75M	0.2%	32
2020 Q2	$66.8M	Buy	6,675,181 +2,984,874	+81%	+$29.9M	0.29%	27
2020 Q1	$10M	Buy	+3,690,307	New	+$10M	0.06%	49
2018 Q3	–	Sell	-100,000	Closed	-$1.19M	–	99
2018 Q2	$1.19M	Hold	100,000	–	–	0.01%	104
2018 Q1	$1.12M	Hold	100,000	–	–	0.01%	100
2017 Q4	$668K	Hold	100,000	–	–	0.01%	111
2017 Q3	$819K	Hold	100,000	–	–	0.01%	108
2017 Q2	$449K	Hold	100,000	–	–	﹤0.01%	115
2017 Q1	$551K	Hold	100,000	–	–	﹤0.01%	110
2016 Q4	$405K	Hold	100,000	–	–	﹤0.01%	123
2016 Q3	$705K	Hold	100,000	–	–	0.01%	120
2016 Q2	$815K	Hold	100,000	–	–	0.01%	119
2016 Q1	$813K	Hold	100,000	–	–	0.01%	118
2015 Q4	$1.21M	Hold	100,000	–	–	0.01%	117
2015 Q3	$1.2M	Hold	100,000	–	–	0.01%	115
2015 Q2	$1.83M	Buy	+100,000	New	+$1.83M	0.02%	104